EyePoint Plc (EYPT)
18.33
-0.03
(-0.16%)
USD |
NASDAQ |
Mar 03, 16:00
18.33
0.00 (0.00%)
After-Hours: 20:00
EyePoint Research and Development Expense (Annual) : 132.93M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| Ocular Therapeutix, Inc. | 197.10M |
| Viking Therapeutics, Inc. | 344.96M |
| Janux Therapeutics, Inc. | 125.90M |
| Tango Therapeutics, Inc. | 143.92M |